Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison Reid

Showing results (141-150 of 162) with videos related to

Pageof 17
Sort By:
Nature Communications|December 21, 2016
Rare disruptive mutations in ciliary function genes contribute to testicular cancer susceptibilityKevin Litchfield, Max Levy, Darshna Dudakia, et al.
Molecular Cancer Therapeutics|June 11, 2009
Phase I safety, pharmacokinetic, and pharmacogenomic trial of ES-285, a novel marine cytotoxic agent, administered to adult patients with advanced solid tumorsRichard D Baird, Jos Kitzen, Paul A Clarke, et al.
Oncotarget|March 22, 2018
Validation of loci at 2q14.2 and 15q21.3 as risk factors for testicular cancerChey Loveday, Kevin Litchfield, Max Levy, et al.
European Urology|June 25, 2018
Large-scale Analysis Demonstrates Familial Testicular Cancer to have Polygenic AetiologyChey Loveday, Philip Law, Kevin Litchfield, et al.
European Urology|March 12, 2016
Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate CancerPasquale Rescigno, David Lorente, Diletta Bianchini, et al.
The Journal of Infectious Diseases|April 3, 2009
Identification of nevirapine-resistant HIV-1 in the latent reservoir after single-dose nevirapine to prevent mother-to-child transmission of HIV-1Megan Wind-Rotolo, Christine Durand, Lisa Cranmer, et al.
Clinical and Translational Radiation Oncology|October 14, 2022
PEARLS - A multicentre phase II/III trial of extended field radiotherapy for androgen sensitive prostate cancer patients with PSMA-avid pelvic and/or para-aortic lymph nodes at presentationJulia Murray, Clare Cruickshank, Thomas Bird, et al.
Lung Cancer (Amsterdam, Netherlands)|July 6, 2013
A genome-wide association study for malignant mesothelioma riskGemma Cadby, Sutapa Mukherjee, A W Bill Musk, et al.
International Journal of Radiation Oncology, Biology, Physics|March 11, 2025
Stereotactic Body Radiation Therapy for Oligoprogressive Disease in Androgen-Suppressed Prostate Cancer: Primary Endpoint Analysis of the TRAP TrialPriyanka Patel, Sabine Dreibe, Gerhardt Attard, et al.
European Urology|December 3, 2014
PTEN protein loss and clinical outcome from castration-resistant prostate cancer treated with abiraterone acetateRoberta Ferraldeschi, Daniel Nava Rodrigues, Ruth Riisnaes, et al.
Pageof 17

Showing results (141-150 of 162) with videos related to

Sort By:
Pageof 17
Nature Communications|December 21, 2016
Rare disruptive mutations in ciliary function genes contribute to testicular cancer susceptibilityKevin Litchfield, Max Levy, Darshna Dudakia, et al.
Molecular Cancer Therapeutics|June 11, 2009
Phase I safety, pharmacokinetic, and pharmacogenomic trial of ES-285, a novel marine cytotoxic agent, administered to adult patients with advanced solid tumorsRichard D Baird, Jos Kitzen, Paul A Clarke, et al.
Oncotarget|March 22, 2018
Validation of loci at 2q14.2 and 15q21.3 as risk factors for testicular cancerChey Loveday, Kevin Litchfield, Max Levy, et al.
European Urology|June 25, 2018
Large-scale Analysis Demonstrates Familial Testicular Cancer to have Polygenic AetiologyChey Loveday, Philip Law, Kevin Litchfield, et al.
European Urology|March 12, 2016
Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate CancerPasquale Rescigno, David Lorente, Diletta Bianchini, et al.
The Journal of Infectious Diseases|April 3, 2009
Identification of nevirapine-resistant HIV-1 in the latent reservoir after single-dose nevirapine to prevent mother-to-child transmission of HIV-1Megan Wind-Rotolo, Christine Durand, Lisa Cranmer, et al.
Clinical and Translational Radiation Oncology|October 14, 2022
PEARLS - A multicentre phase II/III trial of extended field radiotherapy for androgen sensitive prostate cancer patients with PSMA-avid pelvic and/or para-aortic lymph nodes at presentationJulia Murray, Clare Cruickshank, Thomas Bird, et al.
Lung Cancer (Amsterdam, Netherlands)|July 6, 2013
A genome-wide association study for malignant mesothelioma riskGemma Cadby, Sutapa Mukherjee, A W Bill Musk, et al.
International Journal of Radiation Oncology, Biology, Physics|March 11, 2025
Stereotactic Body Radiation Therapy for Oligoprogressive Disease in Androgen-Suppressed Prostate Cancer: Primary Endpoint Analysis of the TRAP TrialPriyanka Patel, Sabine Dreibe, Gerhardt Attard, et al.
European Urology|December 3, 2014
PTEN protein loss and clinical outcome from castration-resistant prostate cancer treated with abiraterone acetateRoberta Ferraldeschi, Daniel Nava Rodrigues, Ruth Riisnaes, et al.
Pageof 17